The Valley Desk

Clinical trial reportClinical and experimental immunologyPublished

Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Lewis Katz School of Medicine, Temple University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical and experimental immunology
Published
Subject terms
Humans; Inflammation; Interleukin-18; Treatment Outcome; Hospitalization; COVID-19; SARS-CoV-2; Pneumonia; Efficacy And Safety; Impaired Respiratory Function; Covid-19; Mas825
PubMed ID
37338154
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal